Historique
Article de Périodique
Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level (2003)
(Effet limité d'une thérapie antirétrovirale très active parmi les usagers de drogues par voie intraveineuse porteurs du VIH en population générale)
Auteur(s) :
VAN ASTEN, L. C. ;
BOUFASSA, F. ;
SCHIFFER, V. ;
BRETTLE, R. P. ;
ROBERTSON, J. R. ;
HERNANDEZ-AGUADO, I. ;
MCMENAMIN, J. ;
ZANGERLE, R. ;
FONTANET A. ;
COUTINHO, R. A. ;
PRINS, M.
Année
2003
Page(s) :
347-349
Langue(s) :
Anglais
Refs biblio. :
22
Domaine :
Drogues illicites / Illicit drugs
Thésaurus mots-clés
SEROPOSITIVITE
;
INJECTION
;
TRAITEMENT
;
EPIDEMIOLOGIE
;
MORTALITE
Thésaurus géographique
EUROPE
;
ESPAGNE
;
ECOSSE
;
PAYS-BAS
;
SUISSE
;
FRANCE
;
AUTRICHE
Note générale :
European Journal of Public health, 2003, 13, (4), 347-349
Note de contenu :
tabl.
Résumé :
ENGLISH :
There is evidence that HIV-positive injecting drug users benefit less than other risk groups from highly active antiretroviral therapy that has been available since 1996. In this multicentre European study the impact of the availability of highly active antiretroviral therapy on the progression rates to AIDS and death among injecting drug users with a documented date of HIV seroconversion is studied. After highly active antiretroviral therapy became available the risk of AIDS and death for injecting drug users decreased by 28% and 36%, which is less than has been reported for other risk groups. (Review' s abstract)
Affiliation :
Municipal Health Service Amsterdam, Cluster Infectious Diseases (room 106), Nieuwe Achtergracht 100, 1000 CE Amsterdam
Pays-Bas. Netherlands.
Pays-Bas. Netherlands.
Cote :
Abonnement